Terrain Bio
Cambridge
About Terrain Bio
Terrain BioSciences is in the field of RNA-based therapeutics and vaccine development. Leveraging advanced AI and proprietary manufacturing platforms, Terrain BioSciences addresses the challenges of designing, selecting, manufacturing, and delivering optimal RNA sequences. Terrain BioSciences collaborates with over a dozen biotech firms to enhance the expression, durability, and manufacturability of RNA sequences, significantly accelerating their path to clinical application. With a focus on personalized cancer vaccines and other RNA-based modalities, Terrain BioSciences is at the forefront of the next generation of programmable medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $9.0M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: terrainbiosciences.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/terrain-bio-83209 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.